SCHEMBL24333399

SCHEMBL24333399

CCn1nc(S(=O)(=O)NC(O)c2cc3c(F)cc(N4CCC4)cc3o2)c2cccnc21

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.33
COMT P21964 1/20 0.30
HTR3A P46098 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29469683 0.84 MAPT (0.32) CCR1COMTHTR3A
SCHEMBL24334224 0.82 NFE2L2 (0.35)
SCHEMBL24334303 0.80 PDE2A (0.30)
SCHEMBL24333964 0.78 HTR6 (0.33)
SCHEMBL24334421 0.76 FABP1 (0.36) COMT
SCHEMBL24333720 0.74 SLC40A1 (0.35)
SCHEMBL24333658 0.74 ALDH1A1 (0.35)
SCHEMBL24333400 0.73 MAPT (0.32) CCR1HTR3A
SCHEMBL24333377 0.73 LMNA (0.34)
SCHEMBL24333639 0.73 TSHR (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed